NPLATE®

(Romiplostim)

Documentation

Patented
Approved 2008
FDA Letter
FDA Label
Full Sequence

Brief Summary

Function Type: Agonist
Target: CD110
Indication Category: Other

Approved Indications

Detailed Summary

Side Effects

References

Wikipedia
Drugs.com
FDA